| Name | Title | Contact Details |
|---|
Pacific Alliance Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Pacific Alliance Medical Center is based in Los Angeles, CA. You can find more information on Pacific Alliance Medical Center at www.pamc.net
Test Equipment Distributors is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A World Leader in Pediatric Healthcare Founded in 1950 by Variety Clubs International, Nicklaus Children s Hospital, formerly Miami Children s Hospital, operates South Florida’s only licensed specialty hospital exclusively for children, with more than 650 attending physicians and over 130 pediatric sub-specialists. The 289-bed nonprofit hospital is renowned for excellence in all aspects of pediatric medicine and routinely has many programs ranked among the nation’s best by U.S. News and World Report. The organization has grown and evolved into the Miami Children s Health System (MCHS) which includes Miami Children s Health Foundation, the organization s 501c3 fundraising arm; a network of eight nonprofit outpatient centers situated in Miami-Dade, Broward and Palm Beach counties; Pediatric Specialty Group, Inc., a nonprofit physician practice subsidiary; a management services organization, and an ambulatory surgery center (opening soon), as well as an e-commerce line of children s wellness and safety products that support the hospital s mission of serving the region’s pediatric population. MCHS is the region’s only healthcare system exclusively for children.
Thompson Health is committed to providing quality health care to our community. Part of that commitment, includes providing information which will enable you to make informed health care decisions.
SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.